VX-661
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Discription | VX-661 is another cystic fibrosis transmembrane conductance regulator (CFTR) corrector in development for the treatment of cystic fibrosis. | ||
---|---|---|---|
Targets |
|
Catalog Num | A12519 |
---|---|
Formula | C26H27F3N2O6 |
Molecular Weight | 520.5 |
CAS Number | 1152311-62-0 |
SMILES | CC(C)(CO)C1=CC2=CC(=C(C=C2N1C[C@H](CO)O)F)NC(=O)C3(CC3)C4=CC5=C(C=C4)OC(O5)(F)F |
Synonyms | VX661, VX 661 |
Storage | Store lyophilized at -20ºC, keep desiccated. |
In vitro | DMSO | 95 mg/mL (182.51 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 19.21 mL | 96.06 mL | 192.12 mL |
0.5 mM | 3.84 mL | 19.21 mL | 38.42 mL |
1 mM | 1.92 mL | 9.61 mL | 19.21 mL |
5 mM | 0.38 mL | 1.92 mL | 3.84 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2